Haemophilus influenzae type b pneumonia in Egyptian children under five years: A step toward the identification of the real burden in our community by the use of real-time polymerase chain reaction  by Deraz, Tharwat et al.
The Egyptian Journal of Medical Human Genetics (2012) 13, 213–218Ain Shams University
The Egyptian Journal of Medical Human Genetics
www.ejmhg.eg.net
www.sciencedirect.comORIGINAL ARTICLEHaemophilus inﬂuenzae type b pneumonia in Egyptian
children under ﬁve years: A step toward the identiﬁcation
of the real burden in our community by the use of
real-time polymerase chain reactionTharwat Deraz a, Mervat Gamal Eldin Mansour a,*, Sherin Albendary b,
Fatma Allam aa Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt
b Department of Microbiology, Ain Shams University, Cairo, EgyptReceived 10 January 2012; accepted 30 January 2012
Available online 28 February 2012*
Eg
E-
11
El
Pe
doKEYWORDS
Haemophilus inﬂuenzae
type b;
Egyptian children;
PCR;
Culture;
Antibiotic sensitivityCorresponding author. Addr
ypt. Tel.: +20 01000837437
mail address: mervatgmanso
10-8630  2012 Ain Shams
sevier B.V. All rights reserve
er review under responsibilit
i:10.1016/j.ejmhg.2012.01.00
Production and hess: Abb
.
ur@gmai
Universit
d.
y of Ain
5
osting by EAbstract Haemophilus inﬂuenzae (Hi) causes more than 3 million cases of serious disease, mainly
meningitis and pneumonia in children less than 5 years old with approximately 386,000 deaths each
year worldwide. The presence or absence of a polysaccharide capsule is an important distinguishing
characteristic of H. inﬂuenzae species. The polysaccharide capsule can be serologically classiﬁed into
six serotypes (a to f). Invasive Hi diseases in children were almost exclusively caused by serotype b
(Hib). To the best of our knowledge, the real burden of Hib pneumonia in Egypt is not clariﬁed.
Yet, few studies are published and concerned with Hib sepsis among neonates or Hib meningitis
in children. We aimed in this study to identify the frequency of Hib pneumonia among Egyptian
children below ﬁve years by the use of real-time polymerase chain reaction (PCR) technique, with
insight on antimicrobial resistance of Hib strains in the Egyptian community. One hundred patientsass Elakad, Nasr City, Cairo,
l.com (M.G.E. Mansour).
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214 T. Deraz et al.with community-acquired pneumonia were investigated for Hib by both real-time PCR and bacte-
rial culture. Haemophilus inﬂuenzae type b was diagnosed in 31% of the examined population by
PCR, with sensitivity of 100% (95% CI: 0.86–1), speciﬁcity 100% (65% CI: 0.93–1), positive pre-
dictive value (PPV) 100% (95% CI: 0.83–1), and negative predictive value (NPV) 100% (95% CI:
0.93–1). Blood culture was positive in 12 patients only, with a sensitivity of 38% (95% CI: 0.22–
0.57), a speciﬁcity of 100% (65% CI: 0.93–1), PPV 100% (95% CI: 0.69–1), and NPV 77%
(95% CI: 0.68–0.86). Isolated Hib strains were sensitive to ceftriaxon in 91% of cases, followed
by ampicillins in 31% and cotrimoxazole in 17%. Three patients had multidrug resistant strains
of Hib.
Conclusion: Haemophilus inﬂuenzae type b infection is still an important and frequent pathogen
causing community-acquired pneumonia in Egypt with changeable antibiotic sensitivity pattern.
PCR represented a sensitive and rapid tool for the diagnosis of Hib pneumonia. Governmental
plans to eradicate Hib in our community with the introduction of Hib conjugate vaccine in the
national immunization program became indispensable.
 2012 Ain Shams University. Production and hosting by Elsevier B.V. All rights reserved.1. Introduction
Haemophilus inﬂuenzae, a gram negative coccobacillus whose
environmental niche is primarily restricted to the human
respiratory tract, is classiﬁed on the basis of the production
of a polysaccharide capsule: strain types a to f produce anti-
genically distinct capsules, and nontypeable strains produce
no capsule [1]. Measurements of the gene contents of H.
inﬂuenzae strains have revealed that the clinical type b Ea-
gan strain possesses 270 kb of additional genomic material
relative to strain Rd, a type d strain that has lost its capsule
and is highly laboratory adapted. More-detailed analysis has
shown that strain Eagan possesses gene regions not found in
Rd, including the cap region genes, encoding the type b cap-
sular polysaccharide; the hif gene cluster, encoding the pilus
adhesion; the hmw1 and hmw2 gene clusters, encoding the
high-molecular-weight adhesions; and the tryptophanase
gene cluster; all related to the virulence factors of Hib
strains [2]. It is estimated that the bacillus causes more than
3 million cases of serious disease, mainly meningitis and
pneumonia in children less than 5 years old with approxi-
mately 386,000 deaths each year worldwide [3]. Invasive Hi
diseases in children were almost exclusively caused by sero-
type b prior to the introduction of H. inﬂuenzae serotype
b conjugate vaccine which had been replaced by nontypeable
strains in several countries [4]. Community-acquired pneu-
monia (CAP) is a common and potentially serious infection
in developing countries especially in children less than ﬁve
years, causing up to 5 million deaths per year [5]. Since
conventional diagnostic tools, such as radiology, microscopy,
culture, and serology, fail to identify responsible pathogens
in many occasions, the development of a PCR assay for
target gene ampliﬁcation has enabled the detection of low
numbers of pathogens in clinical samples [6]. The World
had disposed of H. inﬂuenzae Type b infection since the
production of Hib conjugate vaccine, but what is the
situation in our country? To the best of our knowledge,
Egyptian data about the epidemiology of Hib pneumonia
is lacking. In this study, we aimed to answer this question
through identifying the frequency of Hib among Egyptian
children with CAP under ﬁve years by the use of real-time
polymerase chain reaction technique, with insight on the
antimicrobial resistance of Hib strains in Egyptian
community.2. Patients and methods
2.1. Study settings
This is a cross-sectional observational study involving 100 chil-
dren with community-acquired pneumonia, admitted to the
Ain Shams University Children’s Hospital from February
2009 to December 2009.
2.2. Case deﬁnition and data collection
All children under ﬁve years, of both sexes, with clinical pneu-
monia and were admitted to the hospital were enrolled. We ex-
cluded patients with bronchial asthma, chronic lung diseases,
pulmonary tuberculosis (TB) and patients on antibiotic ther-
apy for the current respiratory condition. According to the
Integrated Management of Childhood Illness (IMCI) program
of WHO, we identiﬁed clinical pneumonia when there is fast
breathing, lower chest indrawing, inability to drink or feed,
or cyanosis [5]. Demographic and clinical data of all patients
together with their chest roentgenogram ﬁndings were
recorded immediate to the enrollment of the patients. Patients
were considered eligible after signing an informed consent by
the parents or the assigned care givers.
2.3. Microbiological culture of Hib
One milliliter of blood was withdrawn from every patient and
inoculated directly into 20 ml of trypticase soy broth in a blood
culture bottle for aerobic culture at 37 C. Positive blood cul-
tures were sub-cultured on supplemented chocolate agar plates
and incubated anaerobically under 10% CO2 atmosphere for
24–48 h. Suspected bacterial colonies were identiﬁed by direct
microscopic examination of Gram stained ﬁlm, biochemical
reaction and serotyping using Hib-speciﬁc antiserum by slide
agglutination test; supplied by Denka-Seiken Co. Ltd., Tokyo,
Japan. Antimicrobial susceptibility by disc diffusion method
was performed for isolated strains.
2.4. Polymerase chain reaction
Total DNA was extracted from patients’ sera using a MagNA
Pure Compact system with MagNA Pure Compact NA isola-
tion kit 1 according to the instructions of the manufacturer
Figure 1 Detection of Hib by PCR. Lanes 3–8 show ampliﬁca-
tion of Hib. Lane 2: negative for Hib.
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o3730964001). Ampliﬁcation by PCR was done by Light
Cycler-DNA Ampliﬁcation Kit SYBR Green I (Cat. No.
2015137). The primer pairs used according to Hassan-King
et al. [7] were for Hib 1 [GCG–AAA–GTG–ACC–TCT–
TAT–CTC–TC] and Hib 2 [GCT–TAC–GCT–TCT–ATC–
TCG–GTG–AA], and were similar and complementary to
the nucleic acid sequence of conserved regions of the bexA
gene speciﬁc for b serotype of H. inﬂuenzae (Fig. 1).
2.5. Statistical analysis
The data were coded, entered and processed on a computer
using SPSS (version 15). The level p< 0.05 was considered
the cut-off value for signiﬁcance. Chi-Square test v2 was used
to test the association variables for categorical data.
Fisher exact test was performed in a table containing values
less than 5. Non-parametric data were tested by the Mann–
Whitney U test. Sensitivity of the culture or m-PCR represents
the proportion of patients with Hib pneumonia that tested po-
sitive. Speciﬁcity is the proportion of patients without Hib
pneumonia that tested negative. Predictive value of a positive
test (PPV) is the proportion of patients with positive tests that
have disease. Predictive value of a negative test (NPV) is the
proportion of patients with negative tests that do not have
disease.
3. Results
3.1. Patients’ cohort characteristics
The age of the studied patients ranged from 15 days of life to ﬁve
years with a median of 8.5 months. In the selected age group,
patients with Hib pneumonia showed signiﬁcant lower age
(median = 2 months, Interquartile range = 1.75–19 months)
compared to non-Hib patients (median = 19 months, Inter-
quartile range = 9–24 months; p= 0.006). Sixty percent of en-
rolled patients was male and 40% was female; however, no
signiﬁcant difference in gender was noticed between patients
with Hib pneumonia and patients without (p> 0.05). None of
the enrolled patients had receivedH. inﬂuenzae type b conjugate
vaccine.
3.2. H. inﬂuenzae pneumonia and its presentation
The presenting symptoms of patients with Hib pneumonia
were indistinguishable from those with non-Hib pneumonia.Fever, cough, expectoration, dyspnea and wheezes were com-
mon presenting symptoms in all studied patients, with signiﬁ-
cant predominance of cough (p= 0.016) and expectoration
(p= 0.01) among patients with Hib pneumonia. Clinical signs
of bronchial breathing, diminished air entry and ﬁne crepita-
tions were detected in all patients groups with signiﬁcant pre-
sentation among non-Hib pneumonia patients. All patients
had evidence of radiological ﬁndings on chest roentgenogram.
Patients with Hib pneumonia had more localized areas of con-
solidation while patients with non-Hib pneumonia had more
diffuse forms of consolidation (p= 0.09) (Table 1).
3.3. H. inﬂuenzae type b detection
Real-time PCR increased the diagnostic yield of Hib among
the studied population. It was able to detect invasive Hae-
mophilus disease in 31 patients who (31%) presented with
CAP under the age of ﬁve while blood culture showed growth
of Hib in 12 patients (12%) only. Real-time PCR had a sensi-
tivity of 100% (95% CI: 0.86–1), a speciﬁcity of 100% (65%
CI: 0.93–1), PPV 100% (95% CI: 0.83–1), NPV 100% (95%
CI: 0.93–1) and diagnostic accuracy of 81%. While bacterial
blood culture had a sensitivity of 38% (95% CI: 0.22–0.57),
a speciﬁcity of 100% (65% CI: 0.93–1), PPV 100% (95% CI:
0.69–1), NPV 77% (95% CI: 0.68–0.86).
4. Discussion
Community-acquired pneumonia (CAP) is one of the most
common serious infections in children. H. inﬂuenzae type b
(Hib) remains one of the most common etiologic agents of
CAP and invasive bacterial infection in children less than ﬁve
years in countries where the Hib vaccine is not used [1,8,9]. We
aimed in this work to have preliminary data about the fre-
quency of Hib pneumonia, as the burden of the disease is still
unclear in Egypt. Yet, no work to facilitate the affordability of
safe and effective Hib immunization appears in recent future
governmental health plans. Moreover, there are no training
programs of health care workers regarding Hib disease surveil-
lance, case deﬁnition, case management and laboratory diag-
nosis. We selected the age group younger than 5 years to be
examined according to previous studies. It indicated that the
highest incidence of hospital admissions due to severe lower
respiratory infections is among children less than 5 years. Ju-
ve`n et al. [10] found 40% of admitted children due to CAP
was less than 5 years. Klien [11] found that more than 52%
of admissions due to community-acquired pneumonia were pa-
tients younger than 5 years. Though Hib conjugate vaccine is
available in the Egyptian market early in this decade; yet it
is not known by a large stratum of Egyptians that are adherent
only to the national vaccination program. Thus unwillingly all
enrolled patients were unvaccinated against Hib infection. We
believe that the identiﬁcation of Hib as a cause of respiratory
disease in these patients is the ﬁrst step in determining how fre-
quently it may cause serious problems and, hence, how hard
we should push governmental health organizations toward
involvement of Hib conjugate vaccine in the national vaccina-
tion program in Egypt especially in the high risk group. Diag-
nosing Hib disease is difﬁcult. To diagnose Hib meningitis,
lumbar punctures must be performed and cerebrospinal ﬂuid
rapidly processed in a microbiological laboratory that has
Table 1 Clinical and radiological characteristics of patients with Hib pneumonia and patients without Hib pneumonia.
Characteristic Patients with Hib pneumonia n= 31 Patients without Hib pneumonia n= 69 Chi-square test
n % N % v2 p-Value
Clinical symptoms
Cough 31 100 55 79.7 5.73 0.016*
Expectoration 12 87 22 70.9 6.29 0.01*
Dyspnea 9 29 31 45 1.65 0.23
Wheeze 17 54.8 24 34.8 3.56 0.06
Clinical signs
Fever 31 100 69 100 2.3 0.13
Sibilant rhonchi 10 32.3 17 24.6 3.56 0.06
Bronchial breathing 12 38.6 53 76.8 14.5 0.04*
Fine crepitations 20 64.5 64 92.8 12.7 0.04*
Decreased air entry 4 12.9 49 71 15.48 0.04*
Respiratory distress 23 74.2 52 75.4 1.66 0.2
Radiological pulmonary inﬁltrate
Localized inﬁltrate 25 80.6 44 63.8 2.85 0.09
Diﬀuse inﬁltrates 6 19.3 25 36.2
* p is signiﬁcant if less than 0.05.
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more difﬁcult to diagnose. Although blood cultures are highly
speciﬁc for Hib, they have a sensitivity of 20%, thus might lead
to underestimated values of Hib pneumonia [4,12,13]. In our
study, we used both bacterial culture and real-time PCR for
optimizing the diagnosis of Hib pneumonia. In this study,
PCR was able to diagnose Hib pneumonia in nearly one-third
(31%) of the children admitted to the hospital due to commu-
nity-acquired pneumonia with a sensitivity of 100% compared
to conﬁrmed positive culture in a 12% of cases with a sensitiv-
ity of 38%. Such spread of Hib pneumonia may be attributable
to continued transmission and circulation of Hib in the adverse
living conditions like household crowding, poverty, and poor
indoor air quality in many of the Egyptian districts among
unvaccinated children. To the best of our knowledge; the ac-
tual incidence of Hib pneumonia in Egyptian children is not
determined yet. Feikin et al. [14] studied Hib meningitis and
pneumonia in 11 developing countries retrospectively and re-
corded 4788 cases of Hib pneumonia out of 100,000 cases of
children below 5 years in Egypt. A previous Egyptian study
claimed that Hib infection rate is low in Egypt based on the
presence of Hib-speciﬁc IgM and IgG in 64.7–75.5% of chil-
dren below 5 years without mentioning the estimated rate
[15]. The incidence of invasive Hib disease and pneumonia
showed three phases of presentation worldwide. Early and be-
fore the introduction of Hib vaccine in 1985, Hib disease was
considered the main cause of mortality-associated invasive
bacterial diseases. In Canada, 10 centers reported 485 cases
of invasive H. inﬂuenzae disease in 1985. In Latin America:
Uruguay and Mexico represented the areas of highest disease
burden and were among the earliest countries that involve
Hib vaccine in their national immunization program [16]. In
Africa and Asia, accurate comprehensive data on the burden
of invasive Hib disease is insufﬁcient. However, in Lombok-
Indonesia, high incidences of Hib meningitis and pneumonia
were reported in children younger than 2 years, from 1998 to
2002. In North America, American Indian and Alaska Native
children have shown the highest risk of Hib disease in USA
[17]. The epidemiology of invasive Hib infection has shifteddramatically in the post-Hib vaccination era. Vaccination
has resulted in impressive reductions in Hib disease and re-
duced carriage of Hib among both vaccinated and non-vacci-
nated individuals through herd immunity [17]. In 2000, eight
years after Canada had implemented their Hib immunization
program, their Immunization Monitoring Program reported
only four cases among children aged 5 years [18]. In a district
in Malawi, Africa, the incidence of H. inﬂuenzae meningitis de-
creased from 20 to 40 per 100,000 to zero in 2005 after the vac-
cine was introduced in 2002 [19]. In The Netherlands, where
vaccination was introduced in 1993, the incidence of invasive
Hib disease among children younger than 5 years of age
dropped from 28.7 per 100,000 in 1992 to 0.8 in 2002 [20]. Sim-
ilar reductions of Hib disease have been observed in most other
countries where vaccination has been implemented in the na-
tional vaccination programs and has almost led to the eradica-
tion of Hib infection [21]. Nevertheless, comparing the studies
is difﬁcult because pneumonia case deﬁnitions, study settings
and methods of case ascertainment, as well as age group of
the study populations differ. Nowadays, Hib disease is chal-
lenging physicians and researchers by a new rise in the rate
of invasive disease. Some researchers described it as the deadly
return of Hib [22]. However, it is difﬁcult to assess whether the
observed increases in rates of H. inﬂuenzae disease are true in-
creases in disease or a result of improved surveillance over the
past 20 years [23]. The observed abrupt increase in invasive
Hib after the introduction of the vaccine has been caused by
strains a and c to f and non-capsulate (nontypeable) strains
which is attributed to be the main adverse event of the vaccine
and shared in the current rise of invasive Hib disease. Where-
fore; Hib remains an important disease pathogen that necessi-
tates continuous surveillance to monitor for shifts in disease
incidence, to understand the burden of invasive H. inﬂuenzae
disease, and to develop public health prevention strategies.
In this study, the majority of patients with Hib pneumonia
were in the ﬁrst 19 months of age with almost half of them
(50%) in their ﬁrst two months after birth; which indicate a
high carriage rate among mothers. This ﬁnding is partly
comparable to MacNeil and coworkers [18] who found that
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years was in infants aged 1 year (63.5%), and (27.7%) in in-
fants aged 1 month. With the emergence of nontypeable organ-
isms, the age incidence of Hib disease signiﬁcantly declined to
less than one year [24]. There was no recorded sex difference
between patients with Hib and patients with non-Hib pneumo-
nia among our studied population. This was in agreement with
the pathophysiology of Hib disease which had no difference in
presentation in both sexes among children [25]. The WHO
published data about the epidemiology of Hib disease with
a slight predominance of Hib infection in certain races
like American Indians, Alaskan Eskimos, Navajo, Apache,
Yakima, Athabaskan, and Australian Aborigines but con-
cluded no differences in sex distribution [1]. Like any other
forms of bacterial pneumonia, fever, refusal to feed, cough
and expectoration were chief presenting symptoms among pa-
tients with Hib pneumonia. Despite the fact that the physical
examination of patients with Hib revealed predominance of
bronchial breathing, diminished air entry and crepitations,
yet physicians cannot differentiate etiological pathogens of
pneumonia by their mere clinical presentation without bacteri-
ological examination. In our study, PCR showed higher diag-
nostic yield than the bacterial culture which was negative in
more than 50% of cases with PCR-proven diagnosis of Hib.
Moreover it also provided rapid and unequivocal results of
isolated Hib. We believe that PCR was particularly important
not only in diagnosis of H. inﬂuenzae disease but also for
typing of Haemophilus strains especially in the era of nontype-
able strains. Many studies concluded that Polymerase chain
reaction is a rapid and sensitive method for the detection of
H. inﬂuenzae type b, which has gained greater importance in
the last few years because it increased the detection rate by
94% [26–29]. Tajima and coworkers [30] recommended PCR
as a robust method for Hib investigation because it can detect
and quantify very small amounts of speciﬁc nucleic acid se-
quences. Though bacterial culture did not add to the diagnos-
tic aspect of this study, yet it enabled us to identify antibiotic
sensitivity and resistance of the isolated Hib colonies. Isolated
Hib showed the highest sensitivity to cephalosporins (namely
ceftriaxon) in 91% of occasions, followed by penicillin (namely
ampicillins) in 33%, with the least sensitivity toward cotrimox-
azole (17%). Multidrug resistant strains were found in 25% of
isolates (n= 3/12). This is completely different from a
previous study in Cairo, Egypt from 1991 to 1993 which
addressed the highest sensitivity of isolated Hib from blood
cultures of children with pneumonia to ampicillins and cotrim-
oxazole in 100% of cases with no recorded antibiotic resistance
[31]. However and comparable to our results, Youssef et al.
[32] studied Hib meningitis in Egyptian children and found
that the majority of isolated strains to be resistant to ampicil-
lins (79%) and chloramphenicol (87%) whereas the highest
sensitivity was to ceftriaxon (100%). Fortunately, H. inﬂuen-
zae antibiotic resistance decreased in many countries from
1997 to 2007 where nationwide campaigns for the prudent
use of antibiotics have been implemented by the health author-
ities and conjugate vaccines against H. inﬂuenzae type b was
introduced globally [31]. However, antibiotic surveillance stud-
ies on this pathogen should be maintained since a rising resis-
tance to amoxicillin and amoxicillin–clavulanic was observed
recently in many localities [28,31]. Moreover antibiotic surveil-
lance studies are necessary to determine trends in national,
regional, and local susceptibility patterns and to effectivelyguide empirical antimicrobial therapy which varies between
localities.
Our study has the limitation of the incapability to deﬁne the
actual burden of Hib disease in our community as it cannot be
calculated using passive, sentinel surveillance because of high
probability of incomplete case ascertainment and the catch-
ment population is usually not expressing the whole commu-
nity. Nevertheless we tried to have preliminary data about
disease frequency in the high risk group of children less than
ﬁve years old which exceeded by far other communities includ-
ing similar resource-limited countries.
5. Conclusion
H. inﬂuenzae type b infection is still an important and frequent
pathogen causing community-acquired pneumonia in Egypt
with changeable antibiotic sensitivity pattern. PCR repre-
sented a sensitive and a rapid tool for the diagnosis of Hib
pneumonia. Governmental plans to eradicate Hib in our com-
munity with the introduction of Hib conjugate vaccine in the
national immunization program became indispensable.
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